Prolonged activation of cannabinoid receptors in human pancreatic islet cells for up to 5 days altered gene expression but did not impair insulin secretion or cell viability, suggesting metabolic dysfunction from cannabis is not driven by direct islet damage.
Read this if you are interested in how the endocannabinoid system affects insulin production and metabolic health.
Chronic cannabinoid receptor activation for 5 days did not impair human islet hormone secretion or cell viability.
What the researchers found
Researchers exposed human pancreatic islets (the cell clusters that produce insulin) to cannabinoid receptor agonists for up to 5 days and measured the effects on gene expression, hormone secretion, and cell survival.
Prolonged activation of both CB1 and CB2 receptors altered the expression of genes encoding endocannabinoid system components, showing the cells adapted to chronic stimulation. However, this adaptation did not translate into impaired function: insulin and glucagon secretion were not significantly affected at 5 days, and cell viability remained intact.
Interestingly, CB2 activation with JWH015 temporarily enhanced insulin and glucagon content at 2 days but this effect normalized by 5 days, suggesting an adaptive response.
The study also characterized the endocannabinoid system in human islets, finding that the enzymes that make and break down endocannabinoids (NAPE-PLD, FAAH, MAGL) were much more abundant than the receptors themselves or the enzyme DAGLalpha.
Why it matters
The endocannabinoid system has been implicated in metabolic dysfunction, and CB1 blockers improved metabolic parameters in clinical trials (rimonabant). This study shows that the metabolic problems associated with endocannabinoid system overactivation in obesity and diabetes are probably not caused by direct damage to the insulin-producing cells.
The numbers in context
Human islets exposed to CB1 and CB2 agonists for up to 5 days. No major effects on insulin or glucagon secretion at 5 days. JWH015 temporarily enhanced hormone content at 2 days. No significant impact on cell viability via caspase assays.
How the study worked
Human pancreatic islets were maintained in culture for 2 and 5 days with or without CB1 (ACEA) or CB2 (JWH015) receptor agonists. Gene expression was measured by RT-PCR, hormone levels by radioimmunoassay, and cell viability by caspase activity assays and morphological assessment.
What this study cannot tell us
In vitro study using isolated islets, which lack the systemic context of blood flow, nerve supply, and hormonal signals present in the body. The 5-day exposure may not capture longer-term effects. The agonist concentrations may not reflect physiological endocannabinoid levels. Human islets from organ donors may have been affected by the donor's health status.
How to read the evidence
Preliminary evidence from an in vitro study of human tissue. The findings are relevant to understanding metabolic disease mechanisms but have limited direct clinical application.
When this study was published
Published in 2016. The role of the endocannabinoid system in metabolic disease continues to be investigated.
The bigger picture
If the metabolic dysfunction in obesity is not due to direct cannabinoid effects on pancreatic islets, then the mechanism must operate elsewhere, likely through effects on fat tissue, the liver, the brain, or systemic inflammation. This narrows the search for how the endocannabinoid system influences metabolic disease.
Questions still open
- If islets are resilient to chronic cannabinoid stimulation, which organs mediate the metabolic dysfunction associated with endocannabinoid overactivation? Would longer exposures (weeks to months) reveal different effects? Does the transient enhancement of hormone content at 2 days have any physiological relevance?
Common questions
Does cannabis affect insulin production?
Why is this relevant to diabetes?
Read the original research
Prolonged activation of human islet cannabinoid receptors in vitro induces adaptation but not dysfunction.
BBA clinical, 5, 143-50
Citation
Vilches-Flores, Alonso; Franklin, Zara; Hauge-Evans, Astrid C; Liu, Bo; Huang, Guo C; Choudhary, Pratik; Jones, Peter M; Persaud, Shanta J. (2016). Prolonged activation of human islet cannabinoid receptors in vitro induces adaptation but not dysfunction.. BBA clinical, 5, 143-50. https://doi.org/10.1016/j.bbacli.2016.03.009
Explore the wider topic
- How THC Affects Your Amygdala: The Brain's Threat Detector and Cannabis
- The Anandamide Connection: Your Body's Natural Bliss Molecule
- How Long for Cannabinoid Receptors to Return to Normal
- Cannabis and the Developing Brain: What Every Teenager (and Parent) Should Know
- Why Can't I Enjoy Anything Without Weed? The Science Behind It
- Dopamine Recovery After Quitting Weed: What the Science Says
- The Endocannabinoid System Explained Simply: What It Does and Why It Matters
- Your Endocannabinoid System Explained: Why Withdrawal Happens
- Your Nervous System After Quitting Weed: Fight or Flight
- Using Weed Under 18: What It Does to Your Developing Brain
- What THC Does to Your Brain: Why Withdrawal Happens
- THC and Your Prefrontal Cortex: What Cannabis Does to Your Decision-Making Brain
- Weed, Cortisol, and Stress: What Cannabis Does to Your Stress Hormones
- Weed and Memory: What the Science Says About THC and Your Hippocampus
- Weed and Motivation: Is Amotivational Syndrome Real?
- Weed and Your Nervous System: What THC Actually Does to Your Brain and Body
- How Weed Rewires Your Reward System (And How to Reset It)